Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Depending on the weight loss and the presence of side effects, the subsequent weekly doses can be adjusted upward or downward
This state-of-the-art weight loss and diabetes medication imitates the functions of hormones GLP-1 and GIP, essential for appetite and blood sugar regulation
However, predictions generated solely by AI are not yet suitable for direct clinical application and must be experimentally validated to confirm their biological significance
Diabetes Metab J 44(6):80218 Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS et al (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
US$ 21.28
US$ 21.92
/assets/images/provider/photos/2775923.jpeg)
US$ 22.51
